Description:
Physician Office In Vitro Diagnostic (IVD) Test Markets, 2022-2027 offers a comprehensive review of trends in global demand for in vitro diagnostic (IVD) products used in physicians’ office laboratories (POLs). The report covers various products including reagents, test kits, standards and controls, and instruments and systems based on immunoassay, clinical chemistry, hematology, molecular, microbiology, and coagulation technologies.
Market Insights
Physicians’ office laboratories are point-of-care (POC) testing sites within traditional practices or urgent care centers staffed by one or more physicians. These laboratories typically utilize portable desktop instruments to deliver rapid diagnostic results, providing essential diagnostic information to support clinical decisions.
Key Highlights
- Macroeconomic and Demographic Indicators: Analysis of factors influencing product demand and growth opportunities.
- Technology Trends: Insights into the types and technologies driving the IVD market from 2022 to 2027.
- Regional Market Projections: Detailed projections of the value of regional and national markets for POL IVD products for the forecast period.
Market Segmentation
- Product Types: Reagents, test kits, standards and controls, instruments, and systems.
- Technologies: Immunoassay, clinical chemistry, hematology, molecular diagnostics, microbiology, and coagulation.
Geographic Coverage
The report includes competitive analysis and regional breakdowns for the United States, Europe, Asia-Pacific, and the rest of the world, with market trends and revenue forecasts through 2027.
For further details and to purchase directly, please contact us.
Sample Report: A sample is available as a PDF upon request.
Table: Market for Physician Office Laboratories with and without COVID-19 testing, 2022-2027 (in millions $)
| Segment | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | CAGR |
| Traditional Physician Office, Total | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | XX% |
| Traditional Physician Office, w/o COVID-19 | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | XX% |
| Urgent Care Total | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | XX% |
| Urgent Care Total w/o COVID-19 |
$XX Million | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | XX% |
Source: Kalorama Information
